Genomics and Artificial Intelligence Working Together in Drug Discovery and Repositioning: The Advent of Adaptive Pharmacogenomics in Glioblastoma and Chronic Arterial Inflammation Therapies

  • Glaucia C. PereiraEmail author


The field of pharmacogenomics investigates how genomics may modulate pathological trends using information on both genotype and phenotype, with the aim of designing personalised healthcare. Homoeostasis is partially regulated through the expression of core protein groups whose functionality is determined at gene level and modulated by environmental factors. Harmful changes in physiology may promote several dis-functionalities. In prior work gene expression was used as a biomarker to assess both pathological propensity and disease progression. A growing body of pharmacogenomics research has developed new compounds, on one hand, and on the other, it has proposed novel therapeutic applications for the existing ones. Over the past decades, collective efforts have significantly increased the number of omics information available. However, efficient and deterministic in silico mechanisms that efficiently analyse and detect trends on the basis of often unknown and limited physiological information responding to challenging clinical questions are still lacking. In this context, computational automation via artificial intelligence methodologies has proven to be accurate, robust to noise, cost efficient, and dynamic dealing with massive databases and forecasting on the basis of the available information. Moreover, this set of computational techniques, based on well-established mathematical models, provide efficient ways of determining trends based on both a priori knowledge and dynamically acquired information, working successfully on incomplete datasets. Therefore, in this chapter we assess developmental similarities between two major causes of worldwide death: glioblastoma and chronic arterial inflammation; and discuss the potential applicability of two artificial intelligence approaches for drug discovery and repositioning. According to the World Health Organization (WHO) a glioblastoma multiform is the most malignant glial-type tumour (graded level IV in the WHO scale); and inflammatory diseases affecting the cardiovascular network are the cause of high mortality. As suggested, these two pathologies have several developmental similarities and share common genetic variants. Therefore, we additionally seek to discuss the main promoters presented in the current literature, aiming at benefiting from their similarities in drug discovery and repositioning, via automatic artificial intelligence pattern recognition, forecasting, and computational design.


Genomics Artificial intelligence Drug discovery Drug repositioning Adaptive pharmacogenomics Glioblastoma Chronic arterial inflammation Genetic fingerprints Deep neural networks Reinforcement learning Inflammatory signalling cascades Cytokines Transcription factors 



Absorption, distribution, metabolism, and excretion


Apolipoprotein E


Adenosine triphosphate


Alpha-thalassaemia X


Casein kinase 2 alpha 1


Deep convolutional networks


Deep learning neural networks


Deoxyribonucleic acid


Deep neural networks


Epidermal growth factor receptor


Glycine-rich regions


Isocitrate dehydrogenase




Low-density lipoprotein


Apolipoprotein A


Leucine zipper


Nuclear factor-kappa B


Oxidized low-density lipoprotein


Phosphatase and tensin homolog


Rel homology domain


Smooth muscle cells


Vascular smooth muscle cells


Salesperson problem


Signal transducer and activator of transcription 3


Transactivation domain


Telomerase reverse transcriptase


Trinitrophenol 470


Tumour protein p53


Vascular cell adhesion molecule 1


World Health Organization



The author is grateful for all those who directly and indirectly contributed to her research. The author is particularly grateful for the support given by the sponsors and collaborators: Prof. Malik, UFMA (; Mr. James, GridPro (; Landspitali (; and the Icelandic Institute for Intelligent Machines (


  1. Aikawa E, Schoen FJ (2014) Calcific and degenerative heart valve disease. In: Willis M, Homeister J, Stone J (eds) Cellular and molecular pathobiology of cardiovascular disease. Elsevier, Amsterdam. doi: 10.1016/B978-0-12-405206-2.00009-0 Google Scholar
  2. Aliper A, Plis S, Artemov A, Ulloa A, Mamoshina P, Zhavoronkov A (2016) Deep learning applications for predicting pharmacological properties of drugs and drug repurposing using transcriptomic data. Mol Pharm 13(7):2524–2530. doi: 10.1021/acs.molpharmaceut.6b00248 PubMedPubMedCentralCrossRefGoogle Scholar
  3. Allavena P, Sica A, Garlanda C, Mantovani A (2008) The Yin-Yang of tumor-associated macrophages in neoplastic progression and immune surveillance. Immunol Rev 222:155–161. doi: 10.1111/j.1600-065X.2008.00607.x PubMedCrossRefGoogle Scholar
  4. Amato F, López A, Peña-Méndez EM, Vaňhara P, Hampl A, Havel J (2013) Artificial neural networks in medical diagnosis. J Appl Biomed 11:47–58. doi: 10.2478/v10136-012-0031-x CrossRefGoogle Scholar
  5. Andersson U, Schwartzbaum J, Wiklund F, Sjostrom S, Liu Y, Tsavachidis S, Ahlbom A, Auvinen A, Collatz-Laier H, Feychting M, Johansen C, Kiuru A, Lonn S, Schoemaker MJ, Swerdlow AJ, Henriksson R, Bondy M, Melin B (2010) A comprehensive study of the association between the EGFR and ERBB2 genes and glioma risk. Acta Oncol 49(6):767–775. doi: 10.3109/0284186X.2010.480980 PubMedCrossRefGoogle Scholar
  6. Anzenbacher P, Zanger UM (2012) Metabolism of drugs and other xenobiotics. Wiley-VCH, Germany. doi: 10.1002/9783527630905 CrossRefGoogle Scholar
  7. Arora S, Barak B (2009) Computational complexity: a modern approach. Complexity 6(January):594Google Scholar
  8. Atkinson AJ, Colburn WA, DeGruttola VG, DeMets DL, Downing GJ, Hoth DF, Oates JA, Peck CC, Schooley RT, Spilker BA, Woodcock J, Zeger SL (2001) Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 69(3):89–95. doi: 10.1067/mcp.2001.113989 CrossRefGoogle Scholar
  9. Baggiolini M, Clark-Lewis I (1992) Interleukin-8, a chemotactic and inflammatory cytokine. FEBS Lett:97–101. doi: 10.1016/0014-5793(92)80909-Z
  10. Barreiro LB, Laval G, Quach H, Patin E, Quintana-Murci L (2008) Natural selection has driven population differentiation in modern humans. Nat Genet 40(3):340–345. doi: 10.1038/ng.78 PubMedCrossRefGoogle Scholar
  11. Barton N, Partridge L (2000) Limits to natural selection. Bioessays 22(12):1075–1084. doi: 10.1002/1521-1878(200012)22:12<1075::AID-BIES5>3.0.CO;2-M PubMedCrossRefGoogle Scholar
  12. Beatty J, Desjardins EC (2009) Natural selection and history. Biol Philos 24(2):231–246. doi: 10.1007/s10539-008-9149-3 CrossRefGoogle Scholar
  13. Bennett CC, Hauser K (2013) Artificial intelligence framework for simulating clinical decision-making: a Markov decision process approach. Artif Intell Med 57(1):9–19. doi: 10.1016/j.artmed.2012.12.003 PubMedCrossRefGoogle Scholar
  14. Bhat KPL, Balasubramaniyan V, Vaillant B, Ezhilarasan R, Hummelink K, Hollingsworth F, Wani K, Heathcock L, James JD, Goodman LD, Conroy S, Long L, Lelic N, Wang S, Gumin J, Raj D, Kodama Y, Raghunathan A, Olar A, Joshi K, Pelloski CE, Heimberger A, Kim SH, Cahill DP, Rao G, DenDunnen WFA, Boddeke HWGM, Phillips HS, Nakano I, Lang FF, Colman H, Sulman EP, Aldape K (2013) Mesenchymal differentiation mediated by NF-κB promotes radiation resistance in Glioblastoma. Cancer Cell 24(3):331–346. doi: 10.1016/j.ccr.2013.08.001 CrossRefPubMedGoogle Scholar
  15. Blondel VD, Tsitsiklis JN (2000) A survey of computational complexity results in systems and control. Automatica 36(9):1249–1274. doi: 10.1016/S0005-1098(00)00050-9 CrossRefGoogle Scholar
  16. Brownlee AEI, Wright JA (2015) Constrained, mixed-integer and multi-objective optimisation of building designs by NSGA-II with fitness approximation. Appl Soft Comput J 33:114–126. doi: 10.1016/j.asoc.2015.04.010 CrossRefGoogle Scholar
  17. Bu G (2009) Apolipoprotein E and its receptors in Alzheimer’s disease: pathways, pathogenesis and therapy. Nat Rev Neurosci 10(5):333–344. doi: 10.1038/nrn2620 PubMedPubMedCentralCrossRefGoogle Scholar
  18. Bullard JH, Mostovoy Y, Dudoit S, Brem RB (2010) Polygenic and directional regulatory evolution across pathways in Saccharomyces. Proc Natl Acad Sci U S A 107(11):5058–5063. doi: 10.1073/pnas.0912959107 PubMedPubMedCentralCrossRefGoogle Scholar
  19. Byrne RP, Bogle IDL (1999) Global optimisation of constrained non-convex programs using reformulation and interval analysis. Comput Chem Eng 23(9):1341–1350. doi: 10.1016/S0098-1354(99)00295-1 CrossRefGoogle Scholar
  20. Caloglu M, Yurut-Caloglu V, Karagol H, Bayir-Angin G, Turan FN, Uzal C (2009) Prognostic factors other than the performance status and age for glioblastoma multiforme: a single-institution experience. J BUON 14(2):211–218PubMedGoogle Scholar
  21. Cancer of the Brain and Other Nervous System—SEER Stat Fact Sheets (2013). Accessed 10 Dec 2016
  22. Candes EJ, Donoho DL (1999) Ridgelets: a key to higher-dimensional intermittency? Philos Trans R Soc A 357(1760):2495–2509. doi: 10.1098/rsta.1999.0444 CrossRefGoogle Scholar
  23. Cao F, Lin S, Xu Z (2010a) Approximation capability of interpolation neural networks. Neurocomputing 74(1–3):457–460. doi: 10.1016/j.neucom.2010.08.018 CrossRefGoogle Scholar
  24. Cao F, Yuan Y, Ding C (2010b) Exact and approximate interpolation for neural networks with single hidden layer. In: 2010 Sixth International Conference on Natural Computation, pp 273–277. doi: 10.1109/ICNC.2010.5583824Google Scholar
  25. Cardiovascular Disease Statistics 2015 BHF (2015). Accessed 10 Dec 2016
  26. Cerami E, Gao J, Dogrusoz U, Gross BE, Sumer SO, Aksoy BA, Jacobsen A, Byrne CJ, Heuer ML, Larsson E, Antipin Y, Reva B, Goldberg AP, Sander C, Schultz N (2012) The cBio cancer genomics portal: an open platform for exploring multidimensional cancer genomics data. Cancer Discov 2(5):401–404. doi: 10.1158/2159-8290.CD-12-0095 PubMedCrossRefGoogle Scholar
  27. Chen Y, Xu D (2003) Computational analyses of high-throughput protein-protein interaction data. Curr Protein Pept Sci 4:159–181. doi: 10.2174/1389203033487225 PubMedCrossRefGoogle Scholar
  28. Ciresan DC, Meier U, Gambardella LM, Schmidhuber J (2010) Deep big simple neural nets excel on handwritten digit recognition. Neural Comput 22(12):1–14. doi: 10.1162/NECO_a_00052 CrossRefGoogle Scholar
  29. Cireşan DC, Meier U, Gambardella LM, Schmidhuber J (2012) Deep big multilayer perceptrons for digit recognition. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). 7700 LECTU, pp 581–598. doi:  10.1007/978-3-642-35289-8-31
  30. Cirulli ET, Goldstein DB (2010) Uncovering the roles of rare variants in common disease through whole-genome sequencing. Nat Rev Genet 11(6):415–425. doi: 10.1038/nrg2779 PubMedCrossRefGoogle Scholar
  31. Clancy S (2008) RNA Functions. Nat Educ 1(1):102Google Scholar
  32. Cohen AL, Holmen SL, Colman H (2013) IDH1 and IDH2 mutations in gliomas. Curr Neurol Neurosci Rep 13(5):345. doi: 10.1007/s11910-013-0345-4 PubMedPubMedCentralCrossRefGoogle Scholar
  33. Cooper GF (1990) The computational complexity of probabilistic inference using bayesian belief networks. Artif Intell 42(2–3):393–405. doi: 10.1016/0004-3702(90)90060-D CrossRefGoogle Scholar
  34. Corder EH, Saunders AM, Risch NJ, Strittmatter WJ, Schmechel DE, Gaskell PC, Rimmler JB, Locke PA, Conneally PM, Schmader KE (1994) Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease. Nat Genet 7(2):180–184. doi: 10.1038/ng0694-180 PubMedCrossRefGoogle Scholar
  35. Craig D, Tinaikar R (2006) Divide and conquer: rethinking IT strategy. McKinsey on IT:1–7Google Scholar
  36. Crouch SPM, Kozlowski R, Slater KJ, Fletcher J (1993) The use of ATP bioluminescence as a measure of cell proliferation and cytotoxicity. J Immunol Methods 160(1):81–88. doi: 10.1016/0022-1759(93)90011-U PubMedCrossRefGoogle Scholar
  37. Dayan P, Balleine BW (2002) Reward, motivation, and reinforcement learning. Neuron 36(2):285–298. doi: 10.1016/S0896-6273(02)00963-7 PubMedCrossRefGoogle Scholar
  38. Debao C (1993) Degree of approximation by superpositions of a sigmoidal function. Approx Theory Its Appl 9(3):17–28. doi: 10.1007/BF02836480 Google Scholar
  39. Di Paolo NC, Shayakhmetov DM (2016) Interleukin 1α and the inflammatory process. Nat Immunol 17(8):906–913. doi: 10.1038/ni.3503 PubMedCrossRefGoogle Scholar
  40. Dietterich T (2000) The divide-and-conquer manifesto. In: Arimura H, Jain S, Sharma A (eds) Algorithmic learning theory. Springer, Berlin, pp 13–26. doi: 10.1002/ieam.196 Google Scholar
  41. Dinarello CA (2009) Immunological and inflammatory functions of the interleukin-1 family. Annu Rev Immunol 27:519–550. doi: 10.1146/annurev.immunol.021908.132612 PubMedCrossRefGoogle Scholar
  42. Dinarello CA (2011) Interleukin-1 in the pathogenesis and treatment of inflammatory diseases. Blood 117(14):3720–3732. doi: 10.1182/blood-2010-07-273417 PubMedPubMedCentralCrossRefGoogle Scholar
  43. Dominiczak AF, McBride MW (2003) Genetics of common polygenic stroke. Nat Genet 35(2):116–117. doi: 10.1038/ng1003-116 PubMedCrossRefGoogle Scholar
  44. Doris PA (2002) Hypertension genetics, single nucleotide polymorphisms, and the common disease: common variant hypothesis. Hypertension 39(2 Pt 2):323–331. doi: 10.1161/hy0202.104087 PubMedCrossRefGoogle Scholar
  45. Dudbridge F (2013) Power and predictive accuracy of polygenic risk scores. PLoS Genet 9(3):e1003348. doi: 10.1371/journal.pgen.1003348 PubMedPubMedCentralCrossRefGoogle Scholar
  46. Dusatkova P, Hradsky O, Lenicek M, Bronsky J, Nevoral J, Kotalova R, Bajerova K, Vitek L, Lukas M, Cinek O (2009) Association of IL23R p.381Gln and ATG16L1 p.197Ala with Crohn disease in the Czech population. J Pediatr Gastroenterol Nutr 49(4):405–410. doi: 10.1097/MPG.0b013e31819344ee PubMedCrossRefGoogle Scholar
  47. Egawa M, Mukai K, Yoshikawa S, Iki M, Mukaida N, Kawano Y, Minegishi Y, Karasuyama H (2013) Inflammatory monocytes recruited to allergic skin acquire an anti-inflammatory M2 phenotype via basophil-derived interleukin-4. Immunity 38(3):570–580. doi: 10.1016/j.immuni.2012.11.014 PubMedCrossRefGoogle Scholar
  48. Escott-Price V, Sims R, Bannister C, Harold D, Vronskaya M, Majounie E, Badarinarayan N, Morgan K, Passmore P, Holmes C, Powell J, Brayne C, Gill M, Mead S, Goate A, Cruchaga C, Lambert JC, Van Duijn C, Maier W, Ramirez A, Holmans P, Jones L, Hardy J, Seshadri S, Schellenberg GD, Amouyel P, Williams J (2015) Common polygenic variation enhances risk prediction for Alzheimer’s disease. Brain 138(12):3673–3684. doi: 10.1093/brain/awv268 PubMedPubMedCentralCrossRefGoogle Scholar
  49. Ferrari S, Stengel RF (2005) Smooth function approximation using neural networks. IEEE Trans Neural Netw 16(1):24–38. doi: 10.1109/TNN.2004.836233 PubMedCrossRefGoogle Scholar
  50. Fischer A, Igel C (2014) Training restricted Boltzmann machines: an introduction. Pattern Recogn 47(1):25–39. doi: 10.1016/j.patcog.2013.05.025 CrossRefGoogle Scholar
  51. Foley JF (2013) Focus issue: understanding mechanisms of inflammation. Sci Signal 6(258):eg2. doi: 10.1126/scisignal.2003938 PubMedCrossRefGoogle Scholar
  52. Fox T, Kriegl JM (2006) Machine learning techniques for in silico modeling of drug metabolism. Curr Top Med Chem 6(15):1579–1591. doi: 10.2174/156802606778108915 PubMedCrossRefGoogle Scholar
  53. Gadji M, Crous AMT, Fortin D, Krcek J, Torchia M, Mai S, Drouin R, Klonisch T (2009) EGF receptor inhibitors in the treatment of glioblastoma multiform: old clinical allies and newly emerging therapeutic concepts. Eur J Pharmacol 625(1–3):23–30. doi: 10.1016/j.ejphar.2009.10.010 PubMedCrossRefGoogle Scholar
  54. Gago J, Landín M, Gallego PP (2010) Strengths of artificial neural networks in modeling complex plant processes. Plant Signal Behav 5(6):743–745. doi: 10.1016/j.jplph.2009.07.007 PubMedPubMedCentralCrossRefGoogle Scholar
  55. Gallistel CR (2005) Deconstructing the law of effect. Games Econ Behav 52(2):410–423. doi: 10.1016/j.geb.2004.06.012 CrossRefGoogle Scholar
  56. Galvão RP, Zong H (2013) Inflammation and gliomagenesis: bi-directional communication at early and late stages of tumor progression. Curr Pathobiol Rep 1(1):19–28. doi: 10.1007/s40139-012-0006-3 PubMedPubMedCentralCrossRefGoogle Scholar
  57. Garcia-Ramos G, Kirkpatrick M (1997) Genetic models of adaptation and gene flow in peripheral populations. Evolution 51(1):21–28. doi: 10.2307/2410956 CrossRefGoogle Scholar
  58. Garey MR, Johnson DS (1979) Computers and intractability: a guide to the theory of np-completeness (Series of Books in the Mathematical Sciences). W. H. Freeman & Co, New York, p 340. doi: 10.1137/1024022 Google Scholar
  59. Gawehn E, Hiss JA, Schneider G (2016) Deep learning in drug discovery. Mol Inform 35(1):3–14. doi: 10.1002/minf.201501008 PubMedCrossRefGoogle Scholar
  60. Graveley BR, Brooks AN, Carlson JW, Duff MO, Landolin JM, Yang L, Artieri CG, van Baren MJ, Boley N, Booth BW, Brown JB, Cherbas L, Davis CA, Dobin A, Li R, Lin W, Malone JH, Mattiuzzo NR, Miller D, Sturgill D, Tuch BB, Zaleski C, Zhang D, Blanchette M, Dudoit S, Eads B, Green RE, Hammonds A, Jiang L, Kapranov P, Langton L, Perrimon N, Sandler JE, Wan KH, Willingham A, Zhang Y, Zou Y, Andrews J, Bickel PJ, Brenner SE, Brent MR, Cherbas P, Gingeras TR, Hoskins RA, Kaufman TC, Oliver B, Celniker SE (2011) The developmental transcriptome of Drosophila melanogaster. Nature 471(7339):473–479. doi: 10.1038/nature09715 PubMedCrossRefGoogle Scholar
  61. Grivennikov SI, Greten FR, Karin M (2010) Immunity, inflammation, and cancer. Cell 140(6):883–899. doi: 10.1016/j.cell.2010.01.025 PubMedPubMedCentralCrossRefGoogle Scholar
  62. Hansen LK, Andersen LN, Kjems U, Larsen J (1996) Revisiting Boltzmann learning: parameter estimation in Markov random fields. In: Proceedings of international conference on acoustics speech and signal processing.Google Scholar
  63. Hansson GK, Hermansson A (2011) The immune system in atherosclerosis. Nat Immunol 12(3):204–212. doi: 10.1038/ni.2001 PubMedCrossRefGoogle Scholar
  64. Hawkins RD, Hon GC, Ren B (2010) Next-generation genomics: an integrative approach. Nat Rev Genet 11(7):476–486. doi: 10.1038/nrg2795 PubMedPubMedCentralGoogle Scholar
  65. He D, Li H, Yusuf N, Elmets CA, Athar M, Katiyar SK, Xu H (2012) IL-17 mediated inflammation promotes tumor growth and progression in the skin. PLoS One 7(2):e32126. doi: 10.1371/journal.pone.0032126 PubMedCentralCrossRefPubMedGoogle Scholar
  66. Heckelei T (2003) Estimation of constrained optimisation models for agricultural supply analysis based on generalised maximum entropy. Eur Rev Agric Econ 30(1):27–50. doi: 10.1093/erae/30.1.27 CrossRefGoogle Scholar
  67. Helbig M, Engelbrecht AP (2014) Population-based metaheuristics for continuous boundary-constrained dynamic multi-objective optimisation problems. Swarm Evol Comput 14:31–47. doi: 10.1016/j.swevo.2013.08.004 CrossRefGoogle Scholar
  68. Hölttä V, Klemetti P, Salo HM, Koivusalo A, Pakarinen M, Westerholm-Ormio M, Kolho K-L, Vaarala O (2013) Interleukin-17 immunity in pediatric Crohn disease and ulcerative colitis. J Pediatr Gastroenterol Nutr 57(3):287–292. doi: 10.1097/MPG.0b013e3182979252 PubMedCrossRefGoogle Scholar
  69. Hopfield JJ (1988) Artificial neural networks. IEEE Circuits Dev Mag 4(5):3–10. doi: 10.1109/101.8118 CrossRefGoogle Scholar
  70. Hopfield J (2007) Hopfield network. Scholarpedia 2(5):1977. doi: 10.4249/scholarpedia.1977 CrossRefGoogle Scholar
  71. Hornik K (1991) Approximation capabilities of multilayer feedforward networks. Neural Netw 4(2):251–257. doi: 10.1016/0893-6080(91)90009-T CrossRefGoogle Scholar
  72. Hornik K, Stinchcombe M, White H (1989) Multilayer feedforward networks are universal approximators. Neural Netw 2(5):359–366. doi: 10.1016/0893-6080(89)90020-8 CrossRefGoogle Scholar
  73. Hornik K, Stinchcombe M, White H (1990) Universal approximation of an unknown mapping and its derivatives using multilayer feedforward networks. Neural Netw 3(5):551–560. doi: 10.1016/0893-6080(90)90005-6 CrossRefGoogle Scholar
  74. Hsieh S-H, Chen C-H (2009) Adaptive image interpolation using probabilistic neural network. Expert Syst Appl 36(3):6025–6029. doi: 10.1016/j.eswa.2008.06.124 CrossRefGoogle Scholar
  75. Hulshof MC, Koot RW, Schimmel EC, Dekker F, Bosch DA, Gonzalez Gonzalez D (2001) Prognostic factors in glioblastoma multiforme. 10 years experience of a single institution. Strahlenther Onkol 177(6):283–290PubMedCrossRefGoogle Scholar
  76. Hutter M (2000) A theory of universal artificial intelligence based on algorithmic complexity. arXiv preprint cs/0004001:1–8. doi: 10.1007/b138233Google Scholar
  77. Ingvarsson PK (2010) Natural selection on synonymous and nonsynonymous mutations shapes patterns of polymorphism in Populus tremula. Mol Biol Evol 27(3):650–660. doi: 10.1093/molbev/msp255 PubMedCrossRefGoogle Scholar
  78. Interleukin-6 Receptor Mendelian Randomisation Analysis (IL6R MR) Consortium (2012) The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis. Lancet 379(9822):1214–1224. doi: 10.1016/S0140-6736(12)60110-X CrossRefGoogle Scholar
  79. Jovanovic K, Siebeck M, Gropp R (2014) The route to pathologies in chronic inflammatory diseases characterized by T helper type 2 immune cells. Clin Exp Immunol 178(2):201–211. doi: 10.1111/cei.12409 PubMedPubMedCentralCrossRefGoogle Scholar
  80. Kaelbling LP, Littman ML, Moore AW (1996) Reinforcement learning: a survey. J Artif Intell Res 4:237–285. doi: 10.1613/jair.301 Google Scholar
  81. Kafi O, Khatib NE, Tiago J, Sequeira A (2017) Numerical simulations of a 3D fluid-structure interaction model for blood flow in an atherosclerotic artery. Math Biosci Eng 14(1):179–193. doi: 10.3934/mbe.2017012 PubMedCrossRefGoogle Scholar
  82. Kaiser D, Freyberg MA, Friedl P (1997) Lack of hemodynamic forces triggers apoptosis in vascular endothelial cells. Biochem Biophys Res Commun 231(3):586–590. doi: 10.1006/bbrc.1997.6146 PubMedCrossRefGoogle Scholar
  83. Katehakis MN, Veinott AF Jr (1987) The multi-armed bandit problem: decomposition and computation. Math Oper Res 12(2):262–268. doi: 10.1287/moor.12.2.262 CrossRefGoogle Scholar
  84. Kathiresan S, Willer C, Peloso G, Demissie S (2008) Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 41(1):56–65. doi: 10.1038/ng.291.Common PubMedPubMedCentralCrossRefGoogle Scholar
  85. Keerthi SS, Gilbert EG (1988) Optimal infinite-horizon feedback laws for a general class of constrained discrete-time systems: stability and moving-horizon approximations. J Optim Theory Appl 57(2):265–293. doi: 10.1007/BF00938540 CrossRefGoogle Scholar
  86. Killela PJ, Pirozzi CJ, Healy P, Reitman, Z. J., Lipp, E., Rasheed, B. A., Yang, R., Diplas, B. H., Wang, Z., Greer, P. K., Zhu, H., Wang, C. Y., Carpenter, A. B., Friedman, H., Friedman, A. H., Keir, S. T., He, J., He, Y., McLendon, R. E., Herndon 2nd, J. E., Yan, H. and Bigner, D. D. (2014) Mutations in IDH1, IDH2, and in the TERT promoter define clinically distinct subgroups of adult malignant gliomas. Oncotarget 5(6):1515–1525. doi: 10.18632/oncotarget.1765Google Scholar
  87. Kim YW, Koul D, Kim SH, Lucio-Eterovic AK, Freire PR, Yao J, Wang J, Almeida JS, Aldape K, Yung WKA (2013) Identification of prognostic gene signatures of glioblastoma: a study based on TCGA data analysis. Neuro-Oncology 15(7):829–839. doi: 10.1093/neuonc/not024 PubMedPubMedCentralCrossRefGoogle Scholar
  88. Kingsolver JG, Hoekstra HE, Hoekstra JM, Berrigan D, Vignieri SN, Hill CE, Hoang A, Gibert P, Beerli P (2001) The strength of phenotypic selection in natural populations. Am Nat 157(3):245–261. doi: 10.1086/319193 PubMedCrossRefGoogle Scholar
  89. Kronzon I (2006) Aortic atherosclerotic disease and stroke. Circulation 114(1):63–75. doi: 10.1161/CIRCULATIONAHA.105.593418 PubMedCrossRefGoogle Scholar
  90. Kumar A, Kumar S, Vikram A, Hoffman TA, Naqvi A, Lewarchik CM, Kim YR, Irani K (2013) Histone and DNA methylation-mediated epigenetic downregulation of endothelial kruppel-like factor 2 by low-density lipoprotein cholesterol. Arterioscler Thromb Vasc Biol 33(8):1936–1942. doi: 10.1161/ATVBAHA.113.301765 PubMedCrossRefGoogle Scholar
  91. Lai RK, Chen Y, Guan X, Nousome D, Sharma C, Canoll P, Bruce J, Sloan AE, Cortes E, Vonsattel JP, Su T, Delgado-Cruzata L, Gurvich I, Santella RM, Ostrom Q, Lee A, Gregersen P, Barnholtz-Sloan J (2014) Genome-wide methylation analyses in glioblastoma multiforme. PLoS One 9(2):e89376. doi: 10.1371/journal.pone.0089376 PubMedPubMedCentralCrossRefGoogle Scholar
  92. Lampert CH (2010) An efficient divide-and-conquer cascade for nonlinear object detection. In: Proceedings of the IEEE Computer Society Conference on Computer Vision and Pattern Recognition, pp 1022–1029. doi: 10.1109/CVPR.2010.5540107Google Scholar
  93. Lange BM (2005) Single-cell genomics. Curr Opin Plant Biol 8(3):236–241. doi: 10.1016/j.pbi.2005.03.015 PubMedCrossRefGoogle Scholar
  94. Lasko TA, Denny JC, Levy MA (2013) Computational phenotype discovery using unsupervised feature learning over noisy, sparse, and irregular clinical data. PLoS One 8(6):e66341. doi: 10.1371/journal.pone.0066341 PubMedPubMedCentralCrossRefGoogle Scholar
  95. Le Cun J, Boser B, Denker JS, Henderson D, Howard RE, Hubbard W, Cun LD, Le B, Denker J, Henderson D (1990) Handwritten digit recognition with a back-propagation network, Advances in neural information processing systems. Morgan Kaufmann Publishers, San Francisco, pp 396–404. doi: 10.1111/dsu.12130 Google Scholar
  96. Leary RJ, Sausen M, Kinde I, Papadopoulos N, Carpten JD, Craig D, O’Shaughnessy J, Kinzler KW, Parmigiani G, Vogelstein B, Diaz LA, Velculescu VE, Shaughnessy JO, Kinzler KW, Parmigiani G, Vogelstein B, Diaz LA Jr, Velculescu VE (2012) Detection of chromosomal alterations in the circulation of cancer patients with whole-genome sequencing. Sci Transl Med 4(162):162ra154. doi: 10.1126/scitranslmed.3004742 PubMedPubMedCentralCrossRefGoogle Scholar
  97. Lecun Y, Bengio Y, Hinton G (2015) Deep learning. Nature 521(1):436–444. doi: 10.1038/nature14539 PubMedCrossRefGoogle Scholar
  98. Li X, Leder P (2007) Identifying genes preferentially expressed in undifferentiated embryonic stem cells. BMC Cell Biol 8:37. doi: 10.1186/1471-2121-8-37 PubMedPubMedCentralCrossRefGoogle Scholar
  99. Li X, Yang Q, Wang Z, Wei D (2014) Shear stress in atherosclerotic plaque determination. DNA Cell Biol 33(12):830–838. doi: 10.1089/dna.2014.2480 PubMedCrossRefGoogle Scholar
  100. Liang Z, Huang JX, Zeng X, Zhang G (2016) DL-ADR: a novel deep learning model for classifying genomic variants into adverse drug reactions. In: From IEEE International Conference on Bioinformatics and Biomedicine, pp 9–12. doi: 10.1186/s12920–016–0207-4Google Scholar
  101. Lima PMV, Morveli-Espinoza MM, Pereira GC, Franga FMG (2005a) SATyrus: a SAT-based neuro-symbolic architecture for constraint processing. In: Fifth International Conference on Hybrid Intelligent Systems (HIS’05), p 6. doi: 10.1109/ICHIS.2005.97Google Scholar
  102. Lima PMV, Pereira GC, Morveli-Espinoza MMM, França FMG (2005b) Mapping and combining combinatorial problems into energy landscapes via Pseudo-boolean Constraints. In: Proceedings of the First International Conference on Brain, Vision, and Artificial Intelligence. Berlin, Springer-Verlag (BVAI’05), pp 308–317. doi: 10.1007/11565123_30Google Scholar
  103. Liu WK, Chen Y, Jun S, Chen J-S, Belytschko T, Pan C, Uras RA, Chang CT (1996) Overview and applications of the reproducing Kernel Particle methods. Arch Comput Meth Eng 3(1):3–80. doi: 10.1007/BF02736130 CrossRefGoogle Scholar
  104. Liu Y, Liu N, Zhao H (2005) Inferring protein—Protein interactions through high-throughput interaction data from diverse organisms. Bioinformatics 21(15):3279–3285. doi: 10.1093/bioinformatics/bti492 PubMedCrossRefGoogle Scholar
  105. Liu C-C, Liu C-C, Kanekiyo T, Xu H, Bu G (2013) Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat Rev Neurol 9(2):106–118. doi: 10.1038/nrneurol.2012.263 PubMedPubMedCentralCrossRefGoogle Scholar
  106. Louis DN, Perry A, Reifenberger G, von Deimling A, Figarella-Branger D, Cavenee WK, Ohgaki H, Wiestler OD, Kleihues P, Ellison DW (2016) The 2016 World Health Organization Classification of Tumors of the Central Nervous System: a summary. Acta Neuropathol 131(6):803–820. doi: 10.1007/s00401-016-1545-1 PubMedCrossRefGoogle Scholar
  107. Lusis AJ (2000) Atherosclerosis. Nature 407(6801):233–241. doi: 10.1038/35025203 PubMedPubMedCentralCrossRefGoogle Scholar
  108. Lvovs D, Favorova OO, Favorov AV (2012) A polygenic approach to the study of polygenic diseases. Acta Nat 4(3):59–71Google Scholar
  109. Mackworth AK, Freuder EC (1985) The complexity of some polynomial network consistency algorithms for constraint satisfaction problems. Artif Intell 25(1):65–74. doi: 10.1016/0004-3702(85)90041-4 CrossRefGoogle Scholar
  110. Mallat S (2016) Understanding deep convolutional networks. arXiv:1–17. doi: 10.1063/1.4939230Google Scholar
  111. Mantovani A, Mantovani A, Allavena P, Allavena P, Sica A, Sica A, Balkwill F, Balkwill F (2008) Cancer-related inflammation. Nature 454(7203):436–444. doi: 10.1038/nature07205 PubMedCrossRefGoogle Scholar
  112. Marieb EN, Hoehn K (2007) Human anatomy and physiology. Physiology 7:664–668. doi: 10.1038/nnano.2011.234 Google Scholar
  113. Metellus P, Nanni-Metellus I, Delfino C, Colin C, Tchogandjian A, Coulibaly B, Fina F, Loundou A, Barrie M, Chinot O, Ouafik L, Figarella-Branger D (2011) Prognostic impact of CD133 mRNA expression in 48 glioblastoma patients treated with concomitant radiochemotherapy: a prospective patient cohort at a single institution. Ann Surg Oncol 18(10):2937–2945. doi: 10.1245/s10434-011-1703-6 PubMedCrossRefGoogle Scholar
  114. Mhaskar HN (1996) Neural networks for optimal approximation of smooth and analytic functions. Neural Comput 8(1):164–177. doi: 10.1162/neco.1996.8.1.164 CrossRefGoogle Scholar
  115. Miyawaki S, Imai H, Takayanagi S, Mukasa A, Nakatomi H, Saito N (2012) Identification of a genetic variant common to moyamoya disease and intracranial major artery stenosis/occlusion. Stroke 43(12):3371–3374. doi: 10.1161/STROKEAHA.112.663864 PubMedCrossRefGoogle Scholar
  116. Moeini R, Afshar MH (2013) Constrained Ant Colony Optimisation Algorithm for the layout and size optimisation of sanitary sewer networks. Urban Water J 10(3):154–173. doi: 10.1080/1573062X.2012.716445 CrossRefGoogle Scholar
  117. Moller F, Smolka SA (1965) On the computational complexity of algorithms. Trans Am Math Soc 117:285. doi: 10.2307/1994208 CrossRefGoogle Scholar
  118. Mozaffarian D, Benjamin EJ, Go AS, Arnett DK, Blaha MJ, Cushman M, Das SR, de Ferranti S, Després J-P, Fullerton HJ, Howard VJ, Huffman MD, Isasi CR, Jiménez MC, Judd SE, Kissela BM, Lichtman JH, Lisabeth LD, Liu S, Mackey RH, Magid DJ, McGuire DK, Mohler ER, Moy CS, Muntner P, Mussolino ME, Nasir K, Neumar RW, Nichol G, Palaniappan L, Pandey DK, Reeves MJ, Rodriguez CJ, Rosamond W, Sorlie PD, Stein J, Towfighi A, Turan TN, Virani SS, Woo D, Yeh RW, Turner MB (2016) Heart disease and stroke statistics—2016 update. Circulation 133(4):e38–e360. doi: 10.1161/CIR.0000000000000350 PubMedCrossRefGoogle Scholar
  119. Naik PP, Somani RR, Wagulde S, Juvatkar P, Kale MK (2015) A review on—Glioblastoma multiform. Pharma Times 47(10):14–18Google Scholar
  120. Napolitano F, Zhao Y, Moreira VM, Tagliaferri R, Kere J, D’Amato M, Greco D (2013) Drug repositioning: a machine-learning approach through data integration. J Cheminform 5(6):30. doi: 10.1186/1758-2946-5-30 PubMedPubMedCentralCrossRefGoogle Scholar
  121. Nebel B (1996) Artificial intelligence: a computational perspective, Principles of knowledge representation, (AUGUST 1997). CSLI Publications, Stanford, pp 237–266Google Scholar
  122. Ng SK, Zhang Z, Tan SH (2003) Integrative approach for computationally inferring protein domain interactions. Bioinformatics 19(8):923–929. doi: 10.1093/bioinformatics/btg118 PubMedCrossRefGoogle Scholar
  123. Nielsen R (2005) Molecular signatures of natural selection. Annu Rev Genet 39(1):197–218. doi: 10.1146/annurev.genet.39.073003.112420 PubMedCrossRefGoogle Scholar
  124. Nivel E, Thórisson KR, Steunebrink BR, Dindo H, Pezzulo G, Rodríguez M, Hernández C, Ognibene D, Schmidhuber J, Sanz R, Helgason HP, Chella A (2014) Bounded seed-AGI. In: Lecture Notes in Computer Science (including subseries Lecture Notes in Artificial Intelligence and Lecture Notes in Bioinformatics). Springer, Cham, pp 85–96. doi:  10.1007/978-3-319-09274-4_9
  125. Nivel E, Thórisson KR, Steunebrink B, Schmidhuber J (2015) Anytime bounded rationality. In: Bieger J, Goertzel B, Potapov A (eds) Artificial general intelligence: 8th international conference, AGI 2015, AGI 2015, Berlin, Germany, July 22–25, 2015, Proceedings. Springer, Cham, pp. 121–130. doi:  10.1007/978-3-319-21365-1_13
  126. Okur V, Cho MT, Henderson L, Retterer K, Schneider M, Sattler S, Niyazov D, Azage M, Smith S, Picker J, Lincoln S, Tarnopolsky M, Brady L, Bjornsson HT, Applegate C, Dameron A, Willaert R, Baskin B, Juusola J, Chung WK (2016) De novo mutations in CSNK2A1 are associated with neurodevelopmental abnormalities and dysmorphic features. Hum Genet 135(7):699–705. doi: 10.1007/s00439-016-1661-y PubMedCrossRefGoogle Scholar
  127. Panagopoulos H, Åström KJ, Hägglund T (2002) Design of PID controllers based on constrained optimisation. IEE P-Contr Theor Ap 149(1):32. doi: 10.1049/ip-cta:20020102 CrossRefGoogle Scholar
  128. Park J, Sandberg IW (1991) Universal Approximation Using Radial-Basis-Function Networks. Neural Comput 3(2):246–257. doi: 10.1162/neco.1991.3.2.246 CrossRefGoogle Scholar
  129. Peng B, Kimmel M (2007) Simulations provide support for the common disease-common variant hypothesis. Genetics 175(2):763–776. doi: 10.1534/genetics.106.058164 PubMedPubMedCentralCrossRefGoogle Scholar
  130. Pizarro TT, De La Rue SA, Cominelli F (2006) Role of interleukin 6 in a murine model of Crohn’s ileitis: are cytokine/anticytokine strategies the future for IBD therapies? Gut 55(9):1226–1227. doi: 10.1136/gut.2005.083121 PubMedPubMedCentralCrossRefGoogle Scholar
  131. Poggio T, Girosi F (2002) Networks for approximation and learning. Proc IEEE 78(9):1481–1497. doi: 10.1109/5.58326 CrossRefGoogle Scholar
  132. Pritchard JK, Cox NJ (2002) The allelic architecture of human disease genes: common disease-common variant...or not? Hum Mol Genet 11(20):2417–2423. doi: 10.1093/hmg/11.20.2417 PubMedCrossRefGoogle Scholar
  133. Purcell SM, Wray NR, Stone JL, Visscher PM, O’Donovan MC, Sullivan PF, Sklar P, Purcell Leader SM, Ruderfer DM, McQuillin A, Morris DW, O’Dushlaine CT, Corvin A, Holmans PA, Macgregor S, Gurling H, Blackwood DHR, Craddock NJ, Gill M, Hultman CM, Kirov GK, Lichtenstein P, Muir WJ, Owen MJ, Pato CN, Scolnick EM, St Clair D, Sklar Leader P, Williams NM, Georgieva L, Nikolov I, Norton N, Williams H, Toncheva D, Milanova V, Thelander EF, Sullivan P, Kenny E, Quinn EM, Choudhury K, Datta S, Pimm J, Thirumalai S, Puri V, Krasucki R, Lawrence J, Quested D, Bass N, Crombie C, Fraser G, Leh Kuan S, Walker N, McGhee KA, Pickard B, Malloy P, Maclean AW, Van Beck M, Pato MT, Medeiros H, Middleton F, Carvalho C, Morley C, Fanous A, Conti D, Knowles JA, Paz Ferreira C, Macedo A, Helena Azevedo M, Kirby AN, Ferreira MAR, Daly MJ, Chambert K, Kuruvilla F, Gabriel SB, Ardlie K, Moran JL (2009) Common polygenic variation contributes to risk of schizophrenia and bipolar disorder. Nature 460(7256):748–752. doi: 10.1038/nature08185 PubMedGoogle Scholar
  134. Qian B-Z, Pollard JW (2010) Macrophage diversity enhances tumor progression and metastasis. Cell 141(1):39–51. doi: 10.1016/j.cell.2010.03.014 PubMedPubMedCentralCrossRefGoogle Scholar
  135. Rabjerg M, Bjerregaard H, Halekoh U, Jensen BL, Walter S, Marcussen N (2016) Molecular characterization of clear cell renal cell carcinoma identifies CSNK2A1, SPP1 and DEFB1 as promising novel prognostic markers. APMIS 124(5):372–383. doi: 10.1111/apm.12519 PubMedCrossRefGoogle Scholar
  136. Rajaraman P, Melin BS, Wang Z, McKean-Cowdin R, Michaud DS, Wang SS, Chanock SJ (2012) Genome-wide association study of glioma and meta-analysis. Hum Genet 131(12):1877–1888. doi: 10.1007/s00439-012-1212-0 PubMedPubMedCentralCrossRefGoogle Scholar
  137. Reneman RS, Arts T, Hoeks APG (2006) Wall shear stress—an important determinant of endothelial cell function and structure—in the arterial system in vivo: discrepancies with theory. J Vasc Res 43(3):251–269. doi: 10.1159/000091648 PubMedCrossRefGoogle Scholar
  138. Rennier K, Ji JY (2013) The role of death-associated protein kinase (DAPK) in endothelial apoptosis under fluid shear stress. Life Sci 93(5–6):194–200. doi: 10.1016/j.lfs.2013.06.011 PubMedCrossRefGoogle Scholar
  139. Robinson R (2010) Common disease, multiple rare (and distant) variants. PLoS Biol 8(1):e1000293. doi: 10.1371/journal.pbio.1000293 PubMedPubMedCentralCrossRefGoogle Scholar
  140. Ross R, Harker L (1976) Hyperlipidemia and atherosclerosis. Science 193(4258):1094–1100. doi: 10.1126/science.822515 PubMedCrossRefGoogle Scholar
  141. Ruiz-Narváez EA, Lunetta KL, Hong C-C, Haddad S, Yao S, Cheng T-YD, Bensen JT, Bandera EV, Haiman CA, Troester MA, Ambrosone CB, Rosenberg L, Palmer JR (2016) Genetic variation in the insulin, insulin-like growth factor, growth hormone, and leptin pathways in relation to breast cancer in African-American women: the AMBER consortium. Npj Breast Cancer 2:16034PubMedPubMedCentralCrossRefGoogle Scholar
  142. Sahin A, Calhan T, Cengiz M, Kahraman R, Aydin K, Ozdil K, Korachi M, Sokmen HM (2014) Serum interleukin 17 levels in patients with Crohn’s disease: real life data. Dis Markers 2014. doi: 10.1155/2014/690853
  143. Sandborn WJ (2000) Therapy for Crohn disease. Curr Opin Gastroenterol 16(4):318–323. doi: 10.1097/00001574-200007000-00005 PubMedCrossRefGoogle Scholar
  144. Sanson M, Hosking FJ, Shete S, Zelenika D, Dobbins SE, Ma Y, Enciso-Mora V, Idbaih A, Delattre JY, Hoang-Xuan K, Marie Y, Boisselier B, Carpentier C, Wang XW, Di Stefano AL, Labussière M, Gousias K, Schramm J, Boland A, Lechner D, Gut I, Armstrong G, Liu Y, Yu R, Lau C, Di Bernardo MC, Robertson LB, Muir K, Hepworth S, Swerdlow A, Schoemaker MJ, Wichmann HE, Müller M, Schreiber S, Franke A, Moebus S, Eisele L, Försti A, Hemminki K, Lathrop M, Bondy M, Houlston RS, Simon M (2011) Chromosome 7p11.2 (EGFR) variation influences glioma risk. Hum Mol Genet 20(14):2897–2904. doi: 10.1093/hmg/ddr192 PubMedPubMedCentralCrossRefGoogle Scholar
  145. Scheller J, Chalaris A, Schmidt-Arras D, Rose-John S (2011) The pro- and anti-inflammatory properties of the cytokine interleukin-6. Biochim Biophys Acta 1813(5):878–888. doi: 10.1016/j.bbamcr.2011.01.034 PubMedCrossRefGoogle Scholar
  146. Schmidhuber J (2015) Deep Learning in neural networks: an overview. Neural Netw 61:85–117. doi: 10.1016/j.neunet.2014.09.003 PubMedCrossRefGoogle Scholar
  147. Schork NJ, Murray SS, Frazer KA, Topol EJ (2009) Common vs. rare allele hypotheses for complex diseases. Curr Opin Genet Dev 19(3):212–219. doi: 10.1016/j.gde.2009.04.010 PubMedPubMedCentralCrossRefGoogle Scholar
  148. Schwender H, Krause A, Ickstadt K (2006) Identifying interesting genes with siggenes. RNews 6:45–50Google Scholar
  149. Selle K, Barrangou R (2015) Harnessing CRISPR-Cas systems for bacterial genome editing. Trends Microbiol 23(4):225–232. doi: 10.1016/j.tim.2015.01.008 PubMedCrossRefGoogle Scholar
  150. Sherwood L (2010) Human physiology: from cells to systems, Human physiology, 7th edn. Brooks/Cole, Pacific Grove, p 766Google Scholar
  151. Shoemaker BA, Panchenko AR (2007) Deciphering protein-protein interactions. Part II. Computational methods to predict protein and domain interaction partners. PLoS Comput Biol 3(4):e43. doi: 10.1371/journal.pcbi.0030043 PubMedPubMedCentralCrossRefGoogle Scholar
  152. Silverthorn D (2010) Human physiology. Pearson, London. doi: 10.1016/j.brainres.2005.11.002 Google Scholar
  153. Slager CJ, Wentzel JJ, Gijsen FJH, Schuurbiers JCH, van der Wal AC, van der Steen AF, Serruys PW (2005) ‘The role of shear stress in the generation of rupture-prone vulnerable plaques. Nat Clin Pract Cardiovasc Med 2(8):401–407. doi: 10.1038/ncpcardio0274 PubMedCrossRefGoogle Scholar
  154. Solberg LA, McGarry PA, Moossy J, Strong JP, Tejada C, Löken AC (1968) Severity of atherosclerosis in cerebral arteries, coronary arteries, and aortas. Ann N Y Acad Sci 149(2):956–973. doi: 10.1111/j.1749-6632.1968.tb53849.x CrossRefGoogle Scholar
  155. Stark AM, Van De Bergh J, Hedderich J, Mehdorn HM, Nabavi A (2012) Glioblastoma: clinical characteristics, prognostic factors and survival in 492 patients. Clin Neurol Neurosurg 114(7):840–845. doi: 10.1016/j.clineuro.2012.01.026 PubMedCrossRefGoogle Scholar
  156. Steinman DA (2002) Image-based computational fluid dynamics modeling in realistic arterial geometries. Ann Biomed Eng 30(4):483–497. doi: 10.1114/1.1467679 PubMedCrossRefGoogle Scholar
  157. Sutton RS, Barto AG (2012) Reinforcement learning. Learning 3(9):322. doi: 10.1109/MED.2013.6608833 Google Scholar
  158. Tafani M, Di Vito M, Frati A, Pellegrini L, De Santis E, Sette G, Eramo A, Sale P, Mari E, Santoro A, Raco A, Salvati M, De Maria R, Russo MA (2011) Pro-inflammatory gene expression in solid glioblastoma microenvironment and in hypoxic stem cells from human glioblastoma. J Neuroinflammation 8(1):32. doi: 10.1186/1742-2094-8-32 PubMedPubMedCentralCrossRefGoogle Scholar
  159. Tang H, Miller-Hooks E (2005) Algorithms for a stochastic selective travelling salesperson problem. J Oper Res Soc 56(4):439–452. doi: 10.1057/palgrave.jors.2601831 CrossRefGoogle Scholar
  160. Tang C, Chen S, Qian H, Huang W (2012) Interleukin-23: as a drug target for autoimmune inflammatory diseases. Immunology 135(2):112–124. doi: 10.1111/j.1365-2567.2011.03522.x PubMedPubMedCentralCrossRefGoogle Scholar
  161. Tedgui A, Mallat Z (2006) Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev 86(2):515–581. doi: 10.1152/physrev.00024.2005 PubMedCrossRefGoogle Scholar
  162. Tesmer LA, Lundy SK, Sarkar S, Fox DA (2008) Th17 cells in human disease. Immunol Rev 223:87–113. doi: 10.1111/j.1600-065X.2008.00628.x PubMedPubMedCentralCrossRefGoogle Scholar
  163. Thiriet M (2014) Anatomy and physiology of the circulatory and ventilatory systems. In: Biomathematical and biomechanical modeling of the circulatory and ventilatory systems. Springer, New York, p 585. doi: 10.1007/978-1-4614-9469-0 Google Scholar
  164. Thon N, Kreth S, Kreth FW (2013) Personalized treatment strategies in glioblastoma: MGMT promoter methylation status. OncoTargets Ther 6:1363–1372. doi: 10.2147/OTT.S50208 CrossRefGoogle Scholar
  165. Thorndike EL (1898) Animal intelligence: an experimental study of the associative processes in animals. Psychol Rev 2(4):1–107. doi: 10.1097/00005053-190001000-00013 Google Scholar
  166. Titz B, Schlesner M, Uetz P (2004) What do we learn from high-throughput protein interaction data? Expert Rev Proteomics 1(1):111–121. doi: 10.1586/14789450.1.1.111 PubMedCrossRefGoogle Scholar
  167. Tsallis C (1988) Possible generalization of Boltzmann-Gibbs statistics. J Stat Phys 52(1–2):479–487. doi: 10.1007/BF01016429 CrossRefGoogle Scholar
  168. Van der Poll T, De Jonge E, Levi M (2001) Regulatory role of cytokines in disseminated intravascular coagulation. Semin Thromb Hemost 27(6):639–651. doi: 10.1055/s-2001-18868 PubMedCrossRefGoogle Scholar
  169. Vivanco I, Ian Robins H, Rohle D, Campos C, Grommes C, Nghiemphu PL, Kubek S, Oldrini B, Chheda MG, Yannuzzi N, Tao H, Zhu S, Iwanami A, Kuga D, Dang J, Pedraza A, Brennan CW, Heguy A, Liau LM, Lieberman F, Alfred Yung WK, Gilbert MR, Reardon DA, Drappatz J, Wen PY, Lamborn KR, Chang SM, Prados MD, Fine HA, Horvath S, Wu N, Lassman AB, DeAngelis LM, Yong WH, Kuhn JG, Mischel PS, Mehta MP, Cloughesy TF, Mellinghoff IK (2012) Differential sensitivity of glioma- versus lung cancer-specific EGFR mutations to EGFR kinase inhibitors. Cancer Discov 2(5):458–471. doi: 10.1158/2159-8290.CD-11-0284 PubMedPubMedCentralCrossRefGoogle Scholar
  170. Wang JH-C, Thampatty BP (2006) An introductory review of cell mechanobiology. Biomech Model Mechanobiol 5(1):1–16. doi: 10.1007/s10237-005-0012-z PubMedCrossRefGoogle Scholar
  171. Wang Y, Putnam CD, Kane MF, Zhang W, Edelmann L, Russell R, Carrión DV, Chin L, Kucherlapati R, Kolodner RD, Edelmann W (2005) Mutation in Rpa1 results in defective DNA double-strand break repair, chromosomal instability and cancer in mice. Nat Genet 37(7):750–755. doi: 10.1038/ng1587 PubMedCrossRefGoogle Scholar
  172. Wang Z, Liu H, Liu B, Ma W, Xue X, Chen J, Zhou Q (2010) Gene expression levels of CSNK1A1 and AAC-11, but not NME1, in tumor tissues as prognostic factors in NSCLC patients. Med Sci Monit 16(8):CR357–CR364PubMedGoogle Scholar
  173. Waples RS (1998) Separating the wheat from the chaff: patterns of genetic differentiation in high gene flow species. J Heredity 89:438–450. doi: 10.1093/jhered/89.5.438 CrossRefGoogle Scholar
  174. Weedon MN, Cebola I, Patch A-M, Flanagan SE, De Franco E, Caswell R, Rodríguez-Seguí SA, Shaw-Smith C, Cho CH-H, Lango Allen H, Houghton JAL, Roth CL, Chen R, Hussain K, Marsh P, Vallier L, Murray A, International Pancreatic Agenesis Consortium, Ellard S, Ferrer J, Hattersley AT (2014) Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis. Nat Genet 46(1):61–64. doi: 10.1038/ng.2826 PubMedCrossRefGoogle Scholar
  175. Wilkins AS, Holliday R (2009) The evolution of meiosis from mitosis. Genetics 181(1):3–12. doi: 10.1534/genetics.108.099762 PubMedPubMedCentralCrossRefGoogle Scholar
  176. Williams K, Bilsland E, Sparkes A, Aubrey W, Young M, Soldatova LN, De Grave K, Ramon J, de Clare M, Sirawaraporn W, Oliver SG, King RD (2015) Cheaper faster drug development validated by the repositioning of drugs against neglected tropical diseases. J R Soc Interface 12(104):20141289. doi: 10.1098/rsif.2014.1289 PubMedPubMedCentralCrossRefGoogle Scholar
  177. Wishart DS, Knox C, Guo AC, Shrivastava S, Hassanali M, Stothard P, Chang Z, Woolsey J (2006) DrugBank: a comprehensive resource for in silico drug discovery and exploration. Nucleic Acids Res 34(90001):D668–D672. doi: 10.1093/nar/gkj067 PubMedCrossRefGoogle Scholar
  178. World Health Organization (2016) WHO/Cardiovascular diseases (CVDs). WHO, GenevaGoogle Scholar
  179. Xu X, Hou Y, Yin X, Bao L, Tang A, Song L, Li F, Tsang S, Wu K, Wu H, He W, Zeng L, Xing M, Wu R, Jiang H, Liu X, Cao D, Guo G, Hu X, Gui Y, Li Z, Xie W, Sun X, Shi M, Cai Z, Wang B, Zhong M, Li J, Lu Z, Gu N, Zhang X, Goodman L, Bolund L, Wang J, Yang H, Kristiansen K, Dean M, Li Y, Wang J (2012) Single-cell exome sequencing reveals single-nucleotide mutation characteristics of a kidney tumor. Cell 148(5):886–895. doi: 10.1016/j.cell.2012.02.025 PubMedCrossRefGoogle Scholar
  180. Yang YH, Xiao Y, Segal MR (2005) Identifying differentially expressed genes from microarray experiments via statistic synthesis. Bioinformatics 21(7):1084–1093. doi: 10.1093/bioinformatics/bti108 PubMedCrossRefGoogle Scholar
  181. Yang S, Ting TO, Man KL, Guan SU (2013) Investigation of neural networks for function approximation. Procedia Comput Sci 17:586–594. doi: 10.1016/j.procs.2013.05.076 CrossRefGoogle Scholar
  182. Yao H, Ang KC, Yeo JH, Sim EK (2000) Computational modelling of blood flow through curved stenosed arteries. J Med Eng Technol 24(4):163–168. doi: 10.1080/03091900050163445 PubMedCrossRefGoogle Scholar
  183. Yao X, Huang J, Zhong H, Shen N, Faggioni R, Fung M, Yao Y (2014) Targeting interleukin-6 in inflammatory autoimmune diseases and cancers. Pharmacol Ther 141(2):125–129. doi: 10.1016/j.pharmthera.2013.09.004 PubMedCrossRefGoogle Scholar
  184. Yasuda M, Tanaka K (2009) Approximate learning algorithm in Boltzmann machines. Neural Comput 21(11):3130–3178. doi: 10.1162/neco.2009.08-08-844 PubMedCrossRefGoogle Scholar
  185. Yingwei L, Sundararajan N, Saratchandran P (1997) A sequential learning scheme for function approximation using minimal radial basis function neural networks. Neural Comput 9(2):461–478. doi: 10.1162/neco.1997.9.2.461 CrossRefGoogle Scholar
  186. Yu X, Wallqvist A, Reifman J (2012) Inferring high-confidence human protein-protein interactions. BMC Bioinformatics 13(1):79. doi: 10.1186/1471-2105-13-79 PubMedPubMedCentralCrossRefGoogle Scholar
  187. Yu J-T, Tan L, Hardy J (2014) Apolipoprotein E in Alzheimer’s disease: an update. Annu Rev Neurosci 37:79–100. doi: 10.1146/annurev-neuro-071013-014300 PubMedCrossRefGoogle Scholar
  188. Zanger UM, Fischer J, Raimundo S, Stüven T, Evert BO, Schwab M, Eichelbaum M (2001) Comprehensive analysis of the genetic factors determining expression and function of hepatic CYP2D6. Pharmacogenetics 11(7):573–585. doi: 10.1097/00008571-200110000-00004 PubMedCrossRefGoogle Scholar
  189. Zanger UM, Raimundo S, Eichelbaum M (2004) Cytochrome P450 2D6: overview and update on pharmacology, genetics, biochemistry. Naunyn Schmiedebergs Arch Pharmacol 369(1):23–37. doi: 10.1007/s00210-003-0832-2 PubMedCrossRefGoogle Scholar
  190. Zanger UM, Turpeinen M, Klein K, Schwab M (2008) Functional pharmacogenetics/genomics of human cytochromes P450 involved in drug biotransformation. Anal Bioanal Chem 392(6):1093–1108. doi: 10.1007/s00216-008-2291-6 PubMedCrossRefGoogle Scholar
  191. Zhang H, Chen J, Liu X, Awar L, Mcmickle A, Bai F, Nagarajan S, Yu S (2013) IL-17 induces expression of vascular cell adhesion molecule through signalling pathway of NF-κB, but not Akt1 and TAK1 in vascular smooth muscle cells. Scand J Immunol 77(4):230–237. doi: 10.1111/sji.12030 PubMedPubMedCentralCrossRefGoogle Scholar
  192. Zhao Y, Kosorok MR, Zeng D (2009) Reinforcement learning design for cancer clinical trials. Stat Med 28(26):3294–3315. doi: 10.1002/sim.3720 PubMedPubMedCentralCrossRefGoogle Scholar

Copyright information

© Springer International Publishing AG 2017

Authors and Affiliations

  1. 1.BiotechnologyIcelandic Institute for Intelligent MachinesReykjavikIceland
  2. 2.Department of Computer SciencesPolytechnic Institute, University Autonoma of MadridMadridSpain
  3. 3.Department of BioengineeringImperial College LondonLondonUK

Personalised recommendations